Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

BioHarvest Sciences Inc. - Common Stock (NQ:BHST)

6.530 -0.120 (-1.80%)
Streaming Delayed Price Updated: 3:19 PM EDT, May 2, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 50,411
Open 6.690
Bid (Size) 6.250 (8)
Ask (Size) 6.660 (2)
Prev. Close 6.650
Today's Range 6.330 - 6.700
52wk Range 4.724 - 6.990
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
BioHarvest Sciences to Host First Quarter 2025 Earnings Call on May 15 at 4:30 p.m. Eastern Time
Rehovot, Israel--(Newsfile Corp. - May 1, 2025) - BioHarvest Sciences Inc. (NASDAQ: BHST) (FSE: 8MV0) ("BioHarvest" or the "Company"), a... 
Via Newsfile
Topics Earnings
Exposures Financial
BioHarvest Sciences Reports Fourth Quarter and Full Year 2024 Financial Results
Fourth Quarter Revenues Grew 62% to $7.3 Million, Exceeding Prior Management Guidance, with Full Year Revenues Increasing 99% Year-Over-Year to... 
Via Newsfile

Performance

YTD
+6.7%
+6.7%
1 Month
+13.8%
+13.8%
3 Month
+30.9%
+30.9%
6 Month
+13.6%
+13.6%
1 Year
+13.6%
+13.6%

More News

Read More
BioHarvest Sciences to Host Fourth Quarter and Full Year 2024 Earnings Call on March 31 at 4:30 p.m. Eastern Time
Via Newsfile
Topics Earnings
Exposures Financial
BioHarvest Sciences to Participate in 37th Annual Roth Conference on March 16-18, 2025
Via Newsfile
Earnings Scheduled For March 31, 2025
Via Benzinga
BioHarvest In Vitro Testing Shows Proprietary Olive Cell Compound Reduces Fat Accumulation in Liver Cells
Via Newsfile
EXCLUSIVE: Botanical Synthesis Tech-Focused BioHarvest's First Synthetic Olive Cells Shows Reduced Fat Accumulation in Liver Cells
Via Benzinga
BioHarvest Announces Sales of Flagship Product VINIA Now Exceed $50 Million USD
Via Newsfile
BioHarvest Sciences to Present at WeBull Consumer Stocks Webinar on February 18
Via Newsfile
BioHarvest Announces Appointment of Sharon Malka to Board of Directors
Via Newsfile
OTC Markets Group Announces Quarterly Index Performance and Rebalancing
From OTC Markets
Via GlobeNewswire
BioHarvest Issues Shareholder Letter and Provides Corporate Update
Via Newsfile
Tate & Lyle and BioHarvest Announce Partnership to Drive the Future of Ingredients Through Botanical Synthesis Technology
Via Newsfile
EXCLUSIVE: BioHarvest Collaborate With Tate & Lyle To Develop Proprietary Plant-Based Molecules
Via Benzinga
BioHarvest Sciences Reports Third Quarter 2024 Financial Results
Via Newsfile
BioHarvest Launches VINIA SuperFood Functional Tea Line
Via Newsfile
BioHarvest Sciences to Participate in Noble Capital Markets Emerging Growth Conference on December 3, 2024
Via Newsfile
BioHarvest Sciences to Host Third Quarter 2024 Earnings Call on November 25 at 4:30 P.M. Eastern Time
Via Newsfile
Topics Earnings
Exposures Financial

Frequently Asked Questions

Is BioHarvest Sciences Inc. - Common Stock publicly traded?
Yes, BioHarvest Sciences Inc. - Common Stock is publicly traded.
What exchange does BioHarvest Sciences Inc. - Common Stock trade on?
BioHarvest Sciences Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for BioHarvest Sciences Inc. - Common Stock?
The ticker symbol for BioHarvest Sciences Inc. - Common Stock is BHST on the Nasdaq Stock Market
What is the current price of BioHarvest Sciences Inc. - Common Stock?
The current price of BioHarvest Sciences Inc. - Common Stock is 6.530
When was BioHarvest Sciences Inc. - Common Stock last traded?
The last trade of BioHarvest Sciences Inc. - Common Stock was at 05/02/25 03:19 PM ET
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.